Johnson JR - Search Results

1

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, Rothmann M, Chen G, U KM, Staten AM, Pazdur R. Cohen MH, et al. Among authors: johnson jr. Clin Cancer Res. 2002 May;8(5):935-42. Clin Cancer Res. 2002. PMID: 12006504

2

Accelerated approval of oncology products: a decade of experience.

Dagher R, Johnson J, Williams G, Keegan P, Pazdur R. Dagher R, et al. J Natl Cancer Inst. 2004 Oct 20;96(20):1500-9. doi: 10.1093/jnci/djh279. J Natl Cancer Inst. 2004. PMID: 15494600 Review.

3

Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.

Cohen MH, Johnson JR, Li N, Chen G, Pazdur R. Cohen MH, et al. Among authors: johnson jr. Clin Cancer Res. 2002 Mar;8(3):665-9. Clin Cancer Res. 2002. PMID: 11895893

4

End points and United States Food and Drug Administration approval of oncology drugs.

Johnson JR, Williams G, Pazdur R. Johnson JR, et al. J Clin Oncol. 2003 Apr 1;21(7):1404-11. doi: 10.1200/JCO.2003.08.072. J Clin Oncol. 2003. PMID: 12663734

5

Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.

Johnson JR, Bross P, Cohen M, Rothmann M, Chen G, Zajicek A, Gobburu J, Rahman A, Staten A, Pazdur R. Johnson JR, et al. Clin Cancer Res. 2003 Jun;9(6):1972-9. Clin Cancer Res. 2003. PMID: 12796358 Clinical Trial.

6

U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.

Cohen MH, Johnson JR, Pazdur R. Cohen MH, et al. Among authors: johnson jr. Clin Cancer Res. 2005 Jan 1;11(1):12-9. Clin Cancer Res. 2005. PMID: 15671523 Clinical Trial.

7

Pemetrexed in malignant pleural mesothelioma.

Hazarika M, White RM Jr, Booth BP, Wang YC, Ham DY, Liang CY, Rahman A, Gobburu JV, Li N, Sridhara R, Morse DE, Lostritto R, Garvey P, Johnson JR, Pazdur R. Hazarika M, et al. Among authors: johnson jr. Clin Cancer Res. 2005 Feb 1;11(3):982-92. Clin Cancer Res. 2005. PMID: 15709163

8

Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.

Mann BS, Johnson JR, Kelly R, Sridhara R, Williams G, Pazdur R. Mann BS, et al. Among authors: johnson jr. Clin Cancer Res. 2005 Aug 15;11(16):5671-7. doi: 10.1158/1078-0432.CCR-05-0354. Clin Cancer Res. 2005. PMID: 16115902

9

Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.

Johnson JR, Cohen M, Sridhara R, Chen YF, Williams GM, Duan J, Gobburu J, Booth B, Benson K, Leighton J, Hsieh LS, Chidambaram N, Zimmerman P, Pazdur R. Johnson JR, et al. Clin Cancer Res. 2005 Sep 15;11(18):6414-21. doi: 10.1158/1078-0432.CCR-05-0790. Clin Cancer Res. 2005. PMID: 16166415 Clinical Trial.

10

Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme.

Cohen MH, Johnson JR, Pazdur R. Cohen MH, et al. Among authors: johnson jr. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6767-71. doi: 10.1158/1078-0432.CCR-05-0722. Clin Cancer Res. 2005. PMID: 16203762 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,161 results

Search Page